Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

35results about "Ammonia active ingredients" patented technology

Traditional Chinese medicine suspension eye drops and preparation method thereof

The invention discloses traditional Chinese medicine suspension eye drops and a preparation method thereof, and the traditional Chinese medicine suspension eye drops are prepared from the following raw materials in parts by weight: 1-3 parts of a traditional Chinese medicine composition, 4-7 parts of hydroxypropyl-beta-cyclodextrin, 0.5-2 parts of microcrystalline cellulose-sodium carboxymethyl cellulose and auxiliary materials. The traditional Chinese medicine suspension eye drops provided by the invention abandon a traditional eye ointment form, are directly dropped for use, are convenient to use, have good stability and dispersity, and are excellent in use curative effect and medication experience; on the basis of keeping the clinical efficacy of the Marcher eight-treasure ancient prescription, secondary development and research are scientifically carried out, so that the Marcher eight-treasure ancient prescription plays a greater clinical treatment role, and has a wider market development prospect.
Owner:MAYINGLONG PHARMA GROUP

Application of antitussive agent in preparation of anti-influenza virus drugs

The invention belongs to the field of medicines, and particularly relates to application of a cough relieving agent in preparation of an anti-influenza virus medicine. Through the synergistic effects of resisting viruses, resisting inflammation, regulating mucus secretion and inhibiting nerve sensitization, the antitussive agent relieves influenza symptoms and promotes recovery from the source, has the advantages of being stable in curative effect, small in toxic and side effect, not prone to generating drug resistance, not capable of promoting virus variation and the like, is wider in application stage and application crowd, and can intervene in the early stage of influenza infection. Due to the fact that the antitussive agent can treat influenza caused by exogenous cold and influenza viruses, the antitussive agent can be used in time to relieve symptoms when cough, excessive phlegm and other symptoms are found in the early stage of a patient, the antitussive agent can relieve the exogenous cold for a non-influenza patient, and the antitussive agent can prevent influenza from being converted into severe influenza from mild influenza for an influenza patient. And the reduction of the treatment effect caused by definite diagnosis delay and oseltamivir treatment delay is also avoided.
Owner:TEYI PHARMACEUTICAL GROUP CO LTD

Traditional Chinese medicine composition for treating tumors

The invention discloses a traditional Chinese medicine composition for treating tumors. The invention belongs to the medical field of traditional Chinese medicine for treating tumors. The medicine consists of 21 traditional Chinese medicines such as artemisia anomala, pseudo-ginseng, pseudobulbus cremastrae seu pleiones, rhizoma paridis, dried alum, sal ammoniac and ground beeltle, and comprises plant medicines, mineral medicines and animal medicines. According to the theory that tumor formation is mostly caused by qi and blood stasis, phlegm-damp toxin and stagnation and accumulation and is essentially blood death, stubborn phlegm and rotten water, the traditional Chinese medicine composition is prepared by adopting the method of regulating qi, promoting blood circulation to remove blood stasis, softening hardness to dissipate stagnation, eliminating phlegm, dredging collaterals, clearing away heat and toxic materials, relieving pain, removing rotten water and inducing diuresis as well as strengthening body resistance to eliminate pathogenic factors according to the principle of syndrome differentiation and treatment of traditional Chinese medicine. The method is an empirical method gradually formed by continuous exploration in the practice process. The medicine has a treatment effect on tumors; the traditional Chinese medicine composition also has the effect of relieving and easing pain caused by tumors.
Owner:张建敏

Drugs and methods of administration for the prevention and treatment of viral infections and tumors.

This invention belongs to the field of traditional Chinese medicine technology and discloses drugs and methods of administration for preventing and treating viral infections and tumors. The drugs for preventing and treating viral infections and tumors are divided into two components. By weight, component one includes 0.5-25 parts of ginseng, 1-20 parts of astragalus, 1-18 parts of gastrodia, 1-24 parts of earthworm, 1-26 parts of chuanxiong, 0.1-15 parts of salvia miltiorrhiza, 0.1-10 parts of borneol, 1-28 parts of notoginseng, 1-32 parts of pinellia, 0.1-14 parts of centipede, and 0.1-17 parts of leech. Component two includes 1.5-2.5 parts of borax, 0.5-1.5 parts of potassium nitrate, 1.5-2.5 parts of sal ammoniac, 2-4 parts of agarwood, 4-6 parts of malachite, and 2-4 parts of borneol. This invention combines prevention and treatment. For uninfected individuals, the first component spray can effectively prevent viral infection, while for confirmed patients, the second component powder can kill viruses and tumors, resulting in good therapeutic effects and preventing the disease from worsening and spreading.
Owner:方代吉

Zinc-based materials for caries treatment

Compositions and methods are provided for treating dental caries in individuals and animals. The compositions may be zinc compositions of [Zn(NH3)4]F2. Also provided are methods for producing inorganic zinc compounds (e.g., ZnO, Zn(OH)2, or Zn(OH)F) on the surface of carious lesions. The deposition of inorganic zinc compounds (e.g., ZnO, Zn(OH)2, or Zn(OH)F) reduces the amount of Zn 2+ This can occur by diluting a ZnO / NH3 solution (e.g., an aqueous or alcohol-based solution) into water (e.g., deionized water). The formation of inorganic zinc compounds (e.g., ZnO, Zn(OH)2, or Zn(OH)F) can occur instantaneously upon dilution.
Owner:NEW YORK UNIV

Nitric oxide releasing articles with enhanced albumin affinity and methods for making and using the same

PCT designated stageWO2025245356A1Peptide/protein ingredientsNitro compound active ingredientsThrombusNitric Oxide-Releasing Compound
Described herein are articles comprising a nitric oxide releasing compound and dextran bonded to at least one surface of the article, wherein a sulfonated triazine is covalently bonded to dextran. In one aspect, the articles bind to albumin, which can reduce clotting at the surface of the article and the risk of thrombosis.
Owner:UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC

Liposome composition and pharmaceutical composition

An object of the present invention is to provide a liposome composition and a pharmaceutical composition, which exhibit a high AUC. Provided are a liposome composition including a hydrophilic polymer-modified diacylphosphatidylethanolamine, a dihydrosphingomyelin, and cholesterols as components of a liposome membrane, in which the liposome composition encapsulates a drug, an inner water phase thereof contains ammonium sulfate, and a molar ratio of sulfate ions in the inner water phase to the drug in an entire water phase is 0.36 or more; and a pharmaceutical composition including the liposome composition.
Owner:FUJIFILM CORP

Multi-level targeted composite hydrogel microsphere based on amino fullerene and application of multi-level targeted composite hydrogel microsphere

The invention discloses a multi-level targeting composite hydrogel microsphere based on amino fullerene and an application of the multi-level targeting composite hydrogel microsphere based on amino fullerene, methylacrylate modified aldehyde hyaluronic acid is used as a matrix carrier, amino fullerene is combined with the matrix carrier, and the methylacrylate modified aldehyde hyaluronic acid-fullerene composite hydrogel microsphere is obtained. The macroscopic-cell-mitochondrial multi-layer slow-release targeting effect is achieved, ROS is remarkably reduced in vitro / in vivo, and cartilage repair is promoted. Compared with the prior art, the invention has remarkable innovativeness in targeting precision, release control and curative effect, and is suitable for precise treatment of joint diseases.
Owner:THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIV +1

Traditional Chinese medicine composition for treating nasosinusitis, external ointment and preparation method and application thereof

The invention discloses a traditional Chinese medicine composition for treating nasosinusitis, an external ointment and a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 45 to 55 parts of flos magnoliae liliflorae, 55 to 65 parts of radix angelicae, 25 to 35 parts of flos genkwa, 45 to 55 parts of fructus gleditsiae, 75 to 85 parts of leech, 115 to 125 parts of maggot, 95 to 105 parts of centipeda minima, 25 to 35 parts of fructus xanthii, 55 to 65 parts of muskmelon base, 25 to 35 parts of herba asari, 15 to 25 parts of borneol, 5 to 15 parts of menthol and 15 to 25 parts of sal ammoniac. The biond magnolia flower and the cocklebur fruit are used as monarch drugs, the radix angelicae, the centipeda minima and the asarum are used as ministerial drugs, the lilac daphne flower bud, the leech, the maggot, the muskmelon base, the fructus gleditsiae and the sal ammoniac are used as adjuvant drugs, and the borneol and the menthol are used as conductant drugs, so that a compound structure of dredging orifices, expelling pus and guiding channels is formed, and the traditional Chinese medicine composition is suitable for phlegm-heat congestion type nasosinusitis and is quick in effect and high in cure rate.
Owner:HENAN DULITONG TRADING CO LTD

Compositions and methods of oral supplementation to oral minoxidil for the treatment of alopecia

Embodiments may relate to compositions and methods for treating hair loss, which may include treating alopecia. The compositions and methods relate to oral supplements to oral minoxidil, including an SLC22A9 inducer, a HIF-α inducer, and / or an acidifying agent. Acidifying the blood of patients suffering from alopecia can cause mild acidosis, which can upregulate SLC22A9 and / or downregulate AABC3. Induction of SLC22A9, induction of HIF-α, and / or acidifying the patient's blood can facilitate the entry of oral forms of minoxidil into hair follicles.
Owner:FOLLEA INTERNATIONAL LTD

Application of hydrated electron or preparation thereof in preparation of products for reducing uric acid and resisting inflammation or oxidation

The invention relates to the technical field of biomedicine, in particular to application of hydrated electrons or a hydrated electron preparation in preparation of products for reducing uric acid and resisting inflammation or oxidation. The hydrated electron and the preparation thereof are found to be capable of effectively reducing the uric acid level, have antioxidant and anti-inflammatory effects, have obvious improvement and treatment effects on hyperuricemia, gout and inflammation and lesion of kidneys and joints caused by hyperuricemia and gout, do not have toxic or side effects and adverse reactions on animals, and are suitable for clinical application. The compound has a good application prospect in treatment of hyperuricemia and gout, and a new treatment means is provided for hyperuricemia and gout.
Owner:GUANGZHOU NAT LAB

Traditional Chinese medicine lozenge for esophagus cancer

The invention discloses a traditional Chinese medicine lozenge for treating esophageal cancer, which comprises the following medicinal materials: 40 g of borax, 10 g of agilawood, 25 g of potassium nitrate, 9 g of chlorite schist, 10 g of borneol, 9 g of sal ammoniac, 9 g of clove, 30 g of pseudo-ginseng, 1.5 g of musk and 20 g of granulated sugar, and relates to the technical field of traditional Chinese medicine lozenges. The traditional Chinese medicine composition has the effects of inhibiting cancer cell proliferation and preventing metastasis and relapse, has small burden on the body and is beneficial to disease control.
Owner:王金玉

Method for transient acidification of wounds

This disclosure provides the use of nanoparticles of self-assembled acidic molecular clusters (NP-AMCs) of ammonium salts to lower the pH of skin and underlying tissue of a human or other mammal as a means of stimulating the localized immune response to a wound.
Owner:EARTH SCIENCE LABORATORIES INC

Zinc-based materials for treatment of dental caries

Provided is compositions and methods for treating dental caries in individuals and animals. The compositions may be zinc compositions of [Zn(NH3)4]F2. Also provided are methods of making inorganic zinc compounds (e.g., ZnO, Zn(OH)2, or Zn(OH)F) onto the surface of a carious lesion. The deposition of inorganic zinc compound (e.g., ZnO, Zn(OH)2, or Zn(OH)F) may occur from dilution of a Zn2+ / NH3 solution (e.g., an aqueous or alcohol-based solution) into water (e.g., deionized water). The formation of inorganic zinc compound (e.g., ZnO, Zn(OH)2, or Zn(OH)F) may be instantaneous upon dilution.
Owner:NEW YORK UNIV

Zinc-based materials for treatment of dental caries

Provided is compositions and methods for treating dental caries in individuals and animals. The compositions may be zinc compositions of [Zn(NH3)4]F2. Also provided are methods of making inorganic zinc compounds (e.g., ZnO, Zn(OH)2, or Zn(OH)F) onto the surface of a carious lesion. The deposition of inorganic zinc compound (e.g., ZnO, Zn(OH)2, or Zn(OH)F) may occur from dilution of a Zn2+ / NH3 solution (e.g., an aqueous or alcohol-based solution) into water (e.g., deionized water). The formation of inorganic zinc compound (e.g., ZnO, Zn(OH)2, or Zn(OH)F) may be instantaneous upon dilution.
Owner:NEW YORK UNIV

Traditional Chinese medicine preparation for treating chronic esophagitis and esophageal precancerous lesions and preparation method thereof

PendingCN121422178AAmphibian material medical ingredientsInorganic boron active ingredientsLiver stomachEsophagus Cancers
The invention discloses a traditional Chinese medicine preparation for treating chronic esophagitis and esophageal precancerous lesions and a preparation method thereof. The traditional Chinese medicine preparation is prepared from nux vomica, sal ammoniac, sculellaria barbata, Chinese lobelia, duchesnea indica, marsdenia tenacissima, solanum septemlobum bunge, selfheal, processed pinellia ternate, ginger, coptis chinensis, sticktight, airpotato yam, radix clematidis, borax, platycodon grandiflorum, hawthorn, kelp, seaweed, edible tulip and venenum bufonis. The preparation method comprises the following steps: processing or performing raw treatment on the materials, grinding into fine powder by using a grinder, finely screening by using a sieve, removing coarse stems, and mixing in parts by weight to obtain a finished product of the preparation. The traditional Chinese medicine is simple in preparation method and low in cost, can dissipate blood stasis, regulate liver and stomach and nourish stomach yin, and can effectively treat chronic esophagitis and esophageal precancerous lesions.
Owner:SUIZHOU TENGFU TRADITIONAL CHINESE MEDICINE PHARMACEUTICAL CO LTD

Fluoride-containing aqueous zinc oral care composition

A dental composition is described that includes a homogeneous solution having a zinc complex stabilized with an amine-containing ligand and a fluoride anion source. A method for treating or preventing caries activity on a tooth surface using the dental composition is also described, as are kits.
Owner:SOLVENTUM INTELLECTUAL PROPERTIES CO

Nitric oxide-releasing antibacterial compounds, formulations, and methods pertaining thereto

Several embodiments of NO releasing compounds are disclosed. In some embodiments, the structures are covalently modified to store and release nitric oxide. Some embodiments pertain to methods of making and use of these structures. The compounds may be tailored to release nitric oxide in a controlled manner and can be useful, for example, for treating or preventing microbial infections, or reducing the microbial load of a microbial infection.
Owner:KNOW BIO LLC

Pharmaceutical composition for treating ulcerative colitis and application thereof

The invention discloses a pharmaceutical composition for treating ulcerative colitis and application thereof, and belongs to the field of biological medicine. According to the Mongolian medicine theory guidance, a hot composition containing pomegranate, fructus piperis longi and the like is scientifically compatible with a cold composition containing radix aconiti agrestis buds, musk and the like, and a pharmaceutical composition with a remarkable treatment effect on ulcerative colitis is developed. The pharmaceutical composition realizes multi-target synergistic treatment, can regulate stomach fire, resist inflammation and bacteria, kill stickiness and clear heat, and effectively improves symptoms such as abdominal distension, hypogastralgia, diarrhea and borborygmus of ulcerative colitis patients. The enema is innovatively adopted and directly acts on the colon focus, the first-pass effect is avoided, the medicine utilization rate is increased, and a new treatment strategy is provided for clinical treatment of ulcerative colitis.
Owner:INNER MONGOLIA MEDICAL UNIV

Mongolian medicine composition for treating allergic rhinitis and preparation method thereof

The invention discloses a Mongolian medicine composition for treating allergic rhinitis and a preparation method of the Mongolian medicine composition, and relates to the technical field of Mongolian medicine.The Mongolian medicine composition for treating allergic rhinitis comprises, by weight, 1-100 parts of borneol, 1-100 parts of red sandalwood, 1-100 parts of white sandalwood, 1-100 parts of tabasheer and 1-100 parts of safflower. According to the traditional Chinese medicine composition disclosed by the invention, by virtue of dual mechanisms of remodeling microecological balance of intestinal flora, the symptoms of allergic rhinitis can be effectively relieved, and respiratory tract inflammation injury can be improved.
Owner:那日苏

Ammonia pad with releasable seal

ActiveUS12370150B2Ammonia active ingredientsPharmaceutical non-active ingredientsAdhesivePhysical chemistry
A flexible ammonia pad configured for mounting on the skin of an individual and for sealing and releasing an ammonia inhalant is provided. The pad includes a first flexible impermeable layer having bottom and top surfaces, an adhesive applied to the bottom surface, an ammonia mixture applied to the top surface, and a second flexible impermeable layer covering the top surface. The second layer has at least one outer edge sealed to the first layer and configured to releasably seal the ammonia mixture between the first and second layers. Preferably the ammonia mixture contains 2-15% of ammonia.
Owner:BECRAFT MATTHEW +1

Ammonia odorant

ActiveDE202025103680U1Nervous disorderAmmonia active ingredientsEnvironmental engineeringAmmonia
Ammonia fragrance substance, in particular for multiple use, which contains ammonia solution, characterized in that the ammonia fragrance substance consists of the ammonia solution and at least one superabsorbent (SAPs).
Owner:RUMRICH MARIO

Ammonia pad with releasable seal

A flexible ammonia pad configured for mounting with the skin of an individual includes a first flexible impermeable layer having a bottom surface, an adhesive applied to the first flexible impermeable layer bottom surface, a fiber membrane paper arranged above the first flexible impermeable layer, and a second flexible impermeable layer that seals the ammonia mixture between the first and second flexible layers. The fiber membrane paper is imbued with an ammonia mixture and configured to retain the mixture. The second flexible impermeable layer seals the ammonia mixture via at least one outer edge that is sealed to either the first flexible impermeable layer or the fiber membrane paper. Preferably the second flexible impermeable layer includes a resealable adhesive.
Owner:BECRAFT MATTHEW +1

A traditional Chinese medicine compound gel plaster for cancer pain and a preparation method thereof

This invention discloses a traditional Chinese medicine compound gel patch for cancer pain and its preparation method. The gel patch consists of an active ingredient layer, a gel matrix layer, and an indicator layer. The active ingredient layer includes raw materials such as ammoniac, flavonoids, borneol, prepared frankincense, prepared myrrh, cinnamon, and toad venom, as well as grape skin extract and fish oil. The gel matrix contains methacrylamide gelatin, hibiscus mucin, coptis mucin, chondroitin sulfate, and a photoinitiator. The pH indicator layer contains purple cabbage extract, hibiscus mucin, and coptis mucin. This invention utilizes a nano-drug delivery system to improve component stability and transdermal efficiency, constructs a multi-response interpenetrating network matrix to achieve intelligent drug release, and, guided by traditional Chinese medicine theory, scientifically combines ingredients for multi-pathway synergistic analgesia. Combined with acupuncture and meridian-clearing therapy, it can significantly improve the therapeutic effect of cancer pain. This invention's gel patch has advantages such as programmed biodegradability, biocompatibility, and ease of use.
Owner:SUZHOU TRADITIONAL CHINESE MEDICINE HOSPITAL